MedPath

Influence of Pesticide Exposure on the Occurrence of Hypospadias in Newborns in Picardie

Completed
Conditions
Hypospadias
Interventions
Other: meconium
Other: self questionnaires to parents
Registration Number
NCT02805491
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

We want to see if there is a relationship between exposure to pesticides and the occurrence of hypospade in Picard newborn .

Detailed Description

Hypospadias is the most frequent malformation of the external genital organs in the male infant. Incomplete virilization of the genital bud results in hypoplasia of the tissues on the ventral aspect of the penis, with an ectopic ureteral meatus, a curved penile shaft and an incompletely formed foreskin. The condition is generally isolated and the aetiology is unknown. The pathogenesis is complex and involves hormonal, genetic and environmental factors (which are probably interlinked).

A doubling in the incidence of hypospadias over the last 15 years has emphasized the probable role of environment factors: in fact, certain exogenous compounds (collectively referred to as "endocrine disruptors" (EDs)) may modify hormonal functions and thus exert harmful effects on the organism or its offspring.

The male urethra develops between the 8th and 16th weeks of gestation in an androgen-dependence manner. In utero exposure of the foetus to EDs may have a physiopathological role in the abnormal development of the male genital bud and thus in the development of hypospadia. These EDs are present in many different substances, such as pesticides.

Many epidemiological studies have evidenced an increase in the incidence of hypospadias in children born to exposed parents. Furthermore, animal studies have identified a certain number of compounds associated with hypospadias after in utero exposure. However, human foetal samples have very rarely been assayed in an attempt to measure the true level of impregnation (i.e. the dose received). At present, it is not possible to draw firm conclusions with regard to the true extent of a link between EDs and the increased incidence of hypospadia.

The "HypoMeco" project is a prospective case-control study.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
197
Inclusion Criteria
  • male newborns
  • born after February 1st, 2011, in a maternity hospital/clinic in the Picardie region
Exclusion Criteria
  • refusal to participate,
  • severe associated disorders
  • associated multiple malformation syndromes
  • patients not attending the consultation.
  • parents under the age of 18
  • prison inmates

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
with hypospadiasmeconiumparent-child triads as cases (male newborns with hypospadias)
with hypospadiasself questionnaires to parentsparent-child triads as cases (male newborns with hypospadias)
without hypospadiasmeconiumparent-child triads as controls (male newborns without hypospadias)
without hypospadiasself questionnaires to parentsparent-child triads as controls (male newborns without hypospadias)
Primary Outcome Measures
NameTimeMethod
presence of hypospadia1 month

to compare the incidence of hypospadias in newborns in the Picardie region exposed to pesticides and in those not exposed.

Secondary Outcome Measures
NameTimeMethod
prevalence of hypospadias and each of its forms in the Picardie region1 year

meconium analysis

the proportions of associated endocrine disorders (regardless of the severity of hypospadias) through systematic screening.1 year

meconium analysis

levels of endocrine disruptorsday 1 , 1 month

meconium analysis

Trial Locations

Locations (11)

CH Chauny

🇫🇷

Chauny, France

Groupe Santé Victor Pauchet

🇫🇷

Amiens, France

CH Chateau Thierry

🇫🇷

Chateau Thierry, France

CH Compiegne

🇫🇷

Compiègne, France

CH Abbeville

🇫🇷

Abbeville, France

CHU Amiens

🇫🇷

Amiens, France

CH Creil

🇫🇷

Creil, France

CH Laon

🇫🇷

Laon, France

CH Péronne

🇫🇷

Péronne, France

CH Saint Quentin

🇫🇷

Saint Quentin, France

CH Senlis

🇫🇷

Senlis, France

© Copyright 2025. All Rights Reserved by MedPath